2-Fluoro-4-vinylpyridine, 95% mix TBC as stabilizer, 250mg

2-(3-Hydroxypropyl)isoindoline-1,3-dione, 95.0%, 100g

2-Bromo-1-[4-(dimethylamino)phenyl]ethanone, 97.0%, 250mg

2-Amino-1-(1-methyl-1 H -imidazol-2-yl)-ethanoldihydrochloride, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(oxazol-5-yl)propanoic acid, 97%, 250mg

tert-butyl 2-(methoxymethyl)piperazine-1-carboxylate, 97.0%, 100mg

Hydroxyde de potassium, min 85%, Ph.Eur., en pastilles, 2,5 kg, emballage plastique.

Bromure de tétrabutylammonium (TBAB), min 99 %, pour la synthèse, 250 g, emballage plastique.

2-(2,6-Dioxo-piperidin-3-yl)-4-fluoroisoindoline-1,3-dione, 98.0%, 100g

1-Methyl-2-nitro-3-(trifluoromethyl)benzene, 95.0%, 5g

4-Bromo-6-(tert-butyl)dibenzo[b,d]furan, 95.0%, 1g

N4-(4-METHOXYPHENYL)PYRIDINE-3,4-DIAMINE, 95.0%, 100mg

2-Chloro-3,4-dimethoxybenzoic acid, 97.0%, 100g